Methods of coronary imaging

Details Methods of coronary imaging Methods of coronary imaging

2009-05-04

2011-12-06

Crane, Lawrence E (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

08071566

ABSTRACT:
The present invention provides methods of myocardial perfusion imaging and increasing coronary blood flow of a mammal that are accomplished by administering doses of a compound that is a selective partial A2Areceptor agonist with a short duration of action, in particular regadenoson, useful for, among other indications, myocardial imaging and coronary vasodilation, and determining areas of insufficient blood flow.

REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 4089959 (1978-05-01), Diamond
patent: 4120947 (1978-10-01), Diamond
patent: 4325956 (1982-04-01), Kjellin et al.
patent: 4326525 (1982-04-01), Swanson et al.
patent: 4593095 (1986-06-01), Snyder et al.
patent: 4696932 (1987-09-01), Jacobson et al.
patent: 4804664 (1989-02-01), Kjellin et al.
patent: 4902514 (1990-02-01), Barclay et al.
patent: 4956345 (1990-09-01), Miyasaka et al.
patent: 4968697 (1990-11-01), Hutchison
patent: 4992445 (1991-02-01), Lawter et al.
patent: 5001139 (1991-03-01), Lawter et al.
patent: 5032252 (1991-07-01), Owen et al.
patent: 5070877 (1991-12-01), Mohiuddin et al.
patent: 5189027 (1993-02-01), Miyasita et al.
patent: 5270304 (1993-12-01), Kogi et al.
patent: 5459254 (1995-10-01), Yamaguchi et al.
patent: 5516894 (1996-05-01), Reppert
patent: 5593975 (1997-01-01), Cristalli
patent: 5616345 (1997-04-01), Geoghegan et al.
patent: 5641784 (1997-06-01), Kufner-Muhl et al.
patent: 5646156 (1997-07-01), Jacobsen et al.
patent: 5670498 (1997-09-01), Suzuki et al.
patent: 5703085 (1997-12-01), Suzuki et al.
patent: 5704491 (1998-01-01), Graves
patent: 5705491 (1998-01-01), Yamada
patent: 5770716 (1998-06-01), Khan et al.
patent: 5776960 (1998-07-01), Oppong et al.
patent: 5780481 (1998-07-01), Jacobson et al.
patent: 5854081 (1998-12-01), Linden et al.
patent: 5877180 (1999-03-01), Linden et al.
patent: 5939543 (1999-08-01), Morozumi et al.
patent: 6026317 (2000-02-01), Verani
patent: 6117878 (2000-09-01), Linden
patent: 6214807 (2001-04-01), Zablocki et al.
patent: 6294522 (2001-09-01), Zablocki et al.
patent: 6322771 (2001-11-01), Linden et al.
patent: 6368573 (2002-04-01), Leung
patent: 6387913 (2002-05-01), Mustafa
patent: 6403567 (2002-06-01), Zablocki et al.
patent: 6448235 (2002-09-01), Linden et al.
patent: 6514949 (2003-02-01), Linden et al.
patent: 6552023 (2003-04-01), Zablocki et al.
patent: 6599283 (2003-07-01), Marzilli et al.
patent: 6605597 (2003-08-01), Zablocki et al.
patent: 6642210 (2003-11-01), Zablocki et al.
patent: 6670334 (2003-12-01), Linden et al.
patent: 6677336 (2004-01-01), Zablocki et al.
patent: 6770634 (2004-08-01), Zablocki et al.
patent: 6825349 (2004-11-01), Kalla et al.
patent: 6855818 (2005-02-01), Zablocki et al.
patent: 6916804 (2005-07-01), Castelhano et al.
patent: 6977300 (2005-12-01), Kalla et al.
patent: 6995148 (2006-02-01), Jones et al.
patent: 7109180 (2006-09-01), Zablocki et al.
patent: 7109203 (2006-09-01), Hart et al.
patent: 7125993 (2006-10-01), Elzein et al.
patent: 7144872 (2006-12-01), Zablocki et al.
patent: 7183264 (2007-02-01), Zablocki et al.
patent: 7553823 (2009-06-01), Zablocki et al.
patent: 7582617 (2009-09-01), Belardinelli et al.
patent: 7655636 (2010-02-01), Gordi et al.
patent: 7655637 (2010-02-01), Zablocki et al.
patent: 7671192 (2010-03-01), Zablocki et al.
patent: 7683037 (2010-03-01), Belardinelli
patent: 7732595 (2010-06-01), Zablocki et al.
patent: 2002/0012946 (2002-01-01), Belardinelli et al.
patent: 2003/0235555 (2003-12-01), Shealey et al.
patent: 2004/0038928 (2004-02-01), Zablocki et al.
patent: 2004/0137533 (2004-07-01), Belardinelli et al.
patent: 2004/0198692 (2004-10-01), Zablocki et al.
patent: 2005/0020915 (2005-01-01), Belardinelli et al.
patent: 2006/0052332 (2006-03-01), Zablocki et al.
patent: 2006/0159621 (2006-07-01), Barrett
patent: 2006/0159627 (2006-07-01), Zeng et al.
patent: 2007/0265445 (2007-11-01), Zablocki et al.
patent: 2007/0299089 (2007-12-01), Belardinelli et al.
patent: 2008/0170990 (2008-07-01), Lieu et al.
patent: 2008/0213165 (2008-09-01), Lieu et al.
patent: 2008/0267861 (2008-10-01), Lieu et al.
patent: 2009/0081120 (2009-03-01), Lieu et al.
patent: 2010/0081810 (2010-04-01), Zablocki et al.
patent: 2010/0086483 (2010-04-01), Belardinelli et al.
patent: 965411 (1975-04-01), None
patent: 2064742 (1991-12-01), None
patent: 2377746 (2000-12-01), None
patent: 0 354 638 (1990-02-01), None
patent: 0 386 683 (1990-09-01), None
patent: SHO 48-26038 (1973-08-01), None
patent: HEI 5 1993 9197 (1993-01-01), None
patent: WO 92/00297 (1992-01-01), None
patent: WO 92/12260 (1992-07-01), None
patent: WO 93/23401 (1993-11-01), None
patent: WO 93/25677 (1993-12-01), None
patent: WO 95/11681 (1995-05-01), None
patent: WO 98/52611 (1998-11-01), None
patent: WO 98/57651 (1998-12-01), None
patent: WO 99/63938 (1999-12-01), None
patent: WO 00/78778 (2000-12-01), None
patent: WO 00/78779 (2000-12-01), None
patent: WO 01/16134 (2001-08-01), None
patent: WO 01/62979 (2001-08-01), None
patent: WO 03/088978 (2003-10-01), None
patent: WO 2004/011010 (2004-02-01), None
patent: WO 2005/082379 (2005-09-01), None
patent: WO 2006/044856 (2006-04-01), None
patent: WO 2006/076698 (2006-07-01), None
patent: WO 2007/092372 (2007-08-01), None
patent: WO 2008/028140 (2008-03-01), None
patent: WO 2008/042796 (2008-04-01), None
patent: WO 2008/063712 (2008-05-01), None
patent: WO 2008/086096 (2008-07-01), None
patent: WO 2008/143667 (2008-11-01), None
patent: WO 2009/076580 (2009-06-01), None
patent: WO 2010/037122 (2010-04-01), None
Glover et al., “Pharmacological Stress Thallium Scintigraphy with 2-Cyclohexylmethylidenehydrazinoadensoine (WRC-0470),” Circulation, 94, 1726-1732 (1996).
Korolkovas, A, Essentials of Molecular Pharmacology—Background for Drug Design, Wiley-Interscience, New York, NY, 1970, only pp. 266-272 supplied.
Bergmann et al., “Oxidation of Hypoxanthines, Bearing 8-Aryl or 8-Pyridyl Substituents, by Bovine Milk Xanthine Oxidase,”, Biochimica et Biophysica Acta, vol. 484, No. 2, pp. 275-289 (1977).
Birdsall et al., “Purine N-Oxides-XL The 3-Acyloxypurine 8-Substitution Reaction: Scope: Syntheses of 8-Substituted Xanthines and Guanines,” Tetrahedron, vol. 27, pp. 5969-5978 (1971).
Blackburn et al., “Adenosine Mediates IL-13-Induced Inflammation and Remodeling in the Lung and interacts in an IL13-Adenosine Amplification Pathway,” J. Clin. Invest. vol. 112, No. 3, pp. 332-344 (2003).
Bruns, “Adenosine Antagonism by Purines, Pteridines and Benzopteridines in Human Fibroblasts,” Biochemical Pharmacology, vol. 30, No. 4, pp. 325-333 (1981).
Buckle et al., “Inhibition of Cyclic Nucleotide Phosphodiesterase by Derivatives of 1,3-Bis(cyclopropylmethyl)xanthine,” J. Med. Chem., vol. 37, pp. 476-485 (1994).
Cerqueira, “The Future of Pharmacologic Stress: Selective A2A Adenosine Receptor Agonists,” Am. J. Cardiol., vol. 94 (2A), pp. 33D-42D (2004).
Cline et al., “Coronary Artery Angiography Using Multislice Computed Tomography Images,” Circulation, vol. 102, pp. 1589-1590, XP002564059 (2000).
Crimi et al., “Purine Derivatives in the Study of Allergic Inflammation in Respiratory Diseases,” Allergy, vol. 52, No. 34, pp. 48-54 (1997).
Cristalli et al., “2-Alkynyl Derivatives of Adenosine 5′-N′ethyluronamide: Selective A2 Adenosine Receptor Agonists with Potent Inhibitory Activity on Platelet Aggretation,” J. Med. Chem., vol. 37, pp. 1720-1726 (1994).
Cushley et al., “Inhaled Adenosine and Guanosine on Airway Resistance in Normal and Asthmatic Subjects,” Br. J. Clin. Pharmacol, vol. 15, No. 2, pp. 161-165 (1983).
Dalpiaz et al., “De Novo Analysis of Receptor Binding Affinity Data of Xanthine Adenosine Receptor Antagonists,” Arzneim-Forsch/Drug Res., vol. 45, No. 3, pp. 230-233 (1995).
Dhalla et al., “Tachycardia Caused by A2A Adenosine Receptor Agonists is Mediated by Direct Sympathoexcitation in Awake Rates,” Journal of Pharmacology and Experimental Therapeutics, USA, vol. 316, No. 2, pp. 695-702, XP00907

Affiliated with

Also associated with

Rating

Methods of coronary imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of coronary imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of coronary imaging will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4270310